Mulago Hospital, Uganda
15
1
1
13
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 15 trials
100.0%
+13.5% vs industry average
33%
5 trials in Phase 3/4
15%
2 of 13 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Effectiveness of Tranexamic Acid in Reducing Blood Loss During Femoral Nail Surgery
Role: collaborator
Uganda Sickle Surveillance Study (US-3)
Role: collaborator
Infective Endocarditis in Developing Countries, a Prospective, Observational, Multicentre Study
Role: collaborator
Fistula Reintegration Pilot
Role: collaborator
Hydroxyurea Therapy for Neurological and Cognitive Protection in Pediatric Sickle Cell Anemia in Uganda ( BRAINSAFE-II )
Role: collaborator
Stool Processing Kit (SPK) Evaluation for Pediatric Tuberculosis (TB)
Role: collaborator
Safe Access: Trial With RemovAid Device
Role: collaborator
Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans
Role: collaborator
Assessment of Safety and Efficacy of CCP
Role: collaborator
Optimizing Hydroxyurea Therapy in Children With SCA In Malaria Endemic Areas
Role: collaborator
Immediate Versus Interval Postpartum Use of the Levonorgestrel Contraceptive Implants: a Randomized Controlled Trial
Role: collaborator
Novel Use Of Hydroxyurea in an African Region With Malaria
Role: collaborator
Children's Surgery in Sub-Saharan Africa
Role: collaborator
Immediate Post-placental Insertion of the Copper T 380A After Cesarean Delivery Versus 6 Week Post-cesarean Insertion
Role: collaborator
Non-Mesh Versus Mesh Method for Inguinal Hernia Repair
Role: collaborator
All 15 trials loaded